Search Materials

Adopting electronic recording and reporting is not simply about choosing a piece of software: it is also about changing how people work. This is not a simple undertaking. This document introduces the key questions to be considered and illustrates what the questions, options and recommendations mean in practice by drawing on examples of recent experience from a variety of countries...

This guide summarizes The Union's experience in developing approaches to integrated TB-HIV care for adults in resource-limited settings. It is recommended for health professionals at the implementation level and national programme staff in charge of policy and practices for collaborative TB-HIV activities.

Although guidelines for population-based TB disease prevalence surveys exist, these cannot readily be used for measuring the prevalence of TB disease among health care workers, specific adaptations are needed. This guide is intended to provide that guidance for the specific setting of health care workers...

The MDR-TB Planning Toolkit is designed to help assist countries develop or strengthen a multidrug-resistant tuberculosis (MDR-TB) component within their national TB strategy or plan. Eight tools contain worksheets to assist the user through key planning steps. The toolkit is intended for countries, technical partners, international organizations, and donors.

This is the seventeenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 204 countries and territories that account for over 99% of the world’s TB cases.

The purpose of this document is to provide operational guidance to NGOs and other CSOs and NTPs or their equivalents in implementing and scaling-up integrated community-based TB prevention, diagnosis, treatment and care using the ENGAGE-TB approach described in the document. The principles are aligned with the Stop TB Strategy and are complementary to existing guidelines for engaging all health care providers (including NGOs) in TB prevention and care as part of a public–private mix.

The Tuberculosis Drug Information Guide, 2nd edition, is derived from Drug-Resistant Tuberculosis: A Survival Guide for Clinicians (2nd edition) produced in 2008. Two additional drugs, ofloxacin and clarithromycin (which are used primarily outside of the US), have been included. This Guide can help any physician, nurse, or pharmacist who participates in the management of patients with TB or LTBI.

A 2-hour webinar covers some common questions around LTBI treatment that may not be addressed in national guidelines, but represent a sample of everyday challenges shared by providers of LTBI care.

A 2-hour webinar focuses on tools and strategies State and local health departments can use to help private providers (including Federally Qualified Health Centers, Community Health Clinics, HMOs, and smaller practice practitioners) get up-to-speed on the diagnosis and treatment of latent TB infection (LTBI).

The latest issue of the New Jersey Medical School Global Tuberculosis Institute’s Cultural Competency newsletter focused on patient advocacy. The issue was released in conjunction with World TB Day. It highlights the moving story of one patient’s experience with a TB diagnosis, and how she helped other TB patients, their loved ones and healthcare providers in the struggle against TB...